Trulieve Cannabis Corp. is a cannabis retailer that cultivates, processes, and distributes cannabis products. The company shows strengths in liquidity with a high current ratio of 5.94, indicating strong short-term financial health. However, concerns arise from negative EBITDA and net margins, suggesting ongoing profitability challenges. Despite a solid gross margin of 59.9%, the significant losses reflected in ROE and ROA raise questions about operational efficiency. The recent 11.07% drop in stock price may indicate market apprehension regarding its financial sustainability.
Loading financial metrics...
Company posted a loss of $-473.5M over the last year, representing 41.6% of revenue.
Strong gross margin of 59.5% reflects healthy unit economics.
Excellent operating cash flow margin of 21.5% indicates high-quality earnings.
Operating cash flow grew 23.8% YoY, demonstrating improving cash conversion.
Excellent liquidity with current ratio of 5.9x ensures operational stability.
Free cash flow grew 14.7% YoY, providing more resources for growth and returns.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)